参考文献/References:
[1] European Stroke Organization,Tendera M, Aboyans V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases:document covering atherosclerotic disease of extra cranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology(ESC)[J]. Eur Heart J,2011,32(22):2851-2906.
[2] Winsor T. Influence of arterial disease on the systolic blood pressure gradients of the extremity[J]. Am J Med Sci,1950,220(2):117-126.
[3] Ouriel K, McDonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease[J].Surgery,1982,91(6):686-693.
[4] Paraskevas KI, Kotsikoris I, Koupidis SA, et al. Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events[J]. Angiology,2010,61(6):521-523.
[5] Argyriou C, Giannoukas AD. Ankle-brachial index remains the most powerful tool for peripheral arterial disease detection in epidemiological studies[J]. Angiology,2013,64(6):483-484.
[6] Rac-Albu M, Iliuta L, Guberna SM, et al. The role of ankle-brachial index for predicting peripheral arterial disease[J]. Maedica(Buchar),2014,9(3):295-302.
[7] Nead KT, Cooke JP, Olin JW, et al. Alternative ankle-brachial index method identifies additional at-risk individuals[J]. J Am Coll Cardiol,2013,62(6):553-559.
[8] Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association[J]. Circulation,2012,126(24):2890-2909.
[9] Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease(compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2013,127(13):1425-1443.
[10] Stein R, Hriljac I, Halperin JL, et al. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease[J]. Vasc Med, 2006,11(1):29-33.
[11] Morillas P, Quiles J, Cordero A, et al.Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome[J]. Am J Cardiol,2009,104(11):1494-1498.
[12] Papa ED, Helber I, Ehrlichmann MR, et al. Ankle-brachial index as a predictor of coronary disease events in elderly patients submitted to coronary angiography[J]. Clinics(Sao Paulo),2013,68(12):1481-1487.
[13] Bendermacher BL, Teijink JA, Willigendael EM, et al. Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study[J]. BMC Cardiovasc Disord,2012,12:59.
[14] Fowkes FG, Rudan D, Rudan I, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet,2013,382(9901):1329-1340.
[15] Banerjee S, Vinas A, Mohammad A, et al. Significance of an abnormal ankle-brachial index in patients with established coronary artery disease with and without associated diabetes mellitus[J]. Am J Cardiol,2014,113(8):1280-1284.
[16] Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients[J]. J Vasc Surg,2015,61(3 Suppl):42S-53S.
[17] Aboyans V, Ho E, Denenberg JO, et al. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects[J]. J Vasc Surg,2008,48(5):1197-1203.
[18] Høyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease[J].J Vasc Surg,2013,58(1):231-238.
[19] Hyun S, Forbang NI, Allison MA, et al. Ankle-brachial index, toe-brachial index, and cardiovascular mortality in persons with and without diabetes mellitus[J]. J Vasc Surg,2014,60(2):390-395.
[20] Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease(updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2011,58(19):2020-2045.
[21] Greenland P, Alpert JS, Beller GA, et al.2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2010,56(25):e50-103.
[22] Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease(updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery[J]. J Vasc Surg,2011,54(5):e32-58.
[23] Vaidya A, Joore MA, Ten Cate-Hoek AJ, et al. Screen or not to screen for peripheral arterial disease: guidance from a decision model[J]. BMC Public Health,2014,14:89.
[24] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease(TASCⅡ)[J]. J Vasc Surg,2007,45(Suppl S):S5-67.
[25] Matoba S, Tatsumi T, Murohara T, et al.Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells(Therapeutic Angiogenesis by Cell Transplantation [TACT] trial)in patients with chronic limb ischemia[J]. Am Heart J,2008,156(5):1010-1018.
[26] Jacomella V, Shenoy A, Mosimann K, et al.The impact of endovascular lower-limb revascularisation on the aortic augmentation index in patients with peripheral arterial disease[J]. Eur J Vasc Endovasc Surg,2013,45(5):497-501.
[27] Lin JS, Olson CM, Johnson ES, et al. The Ankle Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction in Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force[R]. Agency for Healthcare Research and Quality(US),2013 Sep. Report No.: 12-05162-EF-1.
[28] Moyer VA, U.S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement[J]. Ann Intern Med,2013,159(5):342-348.